Human medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation: 11/11/2003, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Temodal, temozolomide, Date of authorisation: 26/01/1999, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 26, Status: Authorised

Article 57 product data

Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 21, Status: Authorised

Mandate, objectives and rules of procedure of the Scientific Advice Working Party (SAWP)

Human medicines European public assessment report (EPAR): Zegalogue, dasiglucagon, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised

Policies and procedures